New Research Identifies Cell Subclusters Driving Muscle and Fat Loss in Pancreatic Cancer

Just now September 30, 2026 1 min read 📰 Medical Xpress

📋 Key Takeaway

Research from the University of Oklahoma identifies three subclusters of cells that contribute to cachexia in pancreatic cancer patients. This discovery could lead to new treatments that improve patient tolerance to cancer therapies. Understanding such medical advancements is crucial for Iran, where cancer treatment and healthcare access are significant issues.

Research published today in Cell identifies three small subclusters of cells that drive pancreatic cancer-induced cachexia, a muscle-wasting and fat-loss condition that makes patients less able to tolerate cancer treatment. The study, led by the University of Oklahoma, could help researchers develop treatments targeting these subclusters.